JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
CALL
Chewy
CHWY
$7.31B
| $8.3M | ﹤0.01% |
304,700
+164,900
| +118% | +$3.14M |
2022 Q3
7 quarters
|
|
2552
Business First Bancshares
BFST
$1,000M
| $8.29M | ﹤0.01% |
380,778
-3,869
| -1% | -$80.7K |
2018 Q2
24 quarters
|
|
2553
National Bank Holdings
NBHC
$1.7B
| $8.28M | ﹤0.01% |
212,071
-76,292
| -26% | -$2.7M |
2013 Q2
44 quarters
|
|
2554
Plains GP Holdings
PAGP
$5.14B
| $8.27M | ﹤0.01% |
439,685
-337,454
| -43% | -$6.19M |
2013 Q4
42 quarters
|
|
2555
Cartesian Therapeutics
RNAC
$224M
| $8.27M | ﹤0.01% |
306,330
+258,825
| +545% | +$6.18M |
2020 Q2
16 quarters
|
|
2556
Annexon
ANNX
$798M
| $8.26M | ﹤0.01% |
1,686,372
+726,724
| +76% | +$3.76M |
2020 Q3
15 quarters
|
|
2557
Hercules Capital
HTGC
$3.13B
| $8.26M | ﹤0.01% |
404,051
-131,320
| -25% | -$2.53M |
2015 Q2
36 quarters
|
|
2558
Cohen & Steers
CNS
$3.79B
| $8.26M | ﹤0.01% |
113,875
-16,386
| -13% | -$1.16M |
2015 Q4
34 quarters
|
|
|
VERV
2559
DELISTED
Verve Therapeutics
VERV
| $8.25M | ﹤0.01% |
1,691,352
+198,302
| +13% | +$1.25M |
2021 Q2
12 quarters
|
|
|
NEE.PRS
2560
NextEra Energy 7.299% Corporate Units
NEE.PRS
$1.96B
| $8.24M | ﹤0.01% |
+166,500
| New | +$8.36M |
2024 Q2
0 quarters
|
|
2561
CVR Energy
CVI
$5.53B
| $8.24M | ﹤0.01% |
307,684
-24,191
| -7% | -$735K |
2013 Q2
44 quarters
|
|
2562
CALL
Nucor
NUE
$54.3B
| $8.22M | ﹤0.01% |
52,000
+9,500
| +22% | +$1.65M |
2023 Q2
4 quarters
|
|
2563
PUT
AstraZeneca
AZN
$243B
| $8.2M | ﹤0.01% |
52,550
+22,550
| +75% | +$3.39M |
2023 Q2
4 quarters
|
|
2564
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
| $8.2M | ﹤0.01% |
83,754
-956
| -1% | -$91.9K |
2013 Q2
44 quarters
|
|
2565
Dycom Industries
DY
$8.29B
| $8.18M | ﹤0.01% |
48,456
+12,638
| +35% | +$1.97M |
2015 Q1
37 quarters
|
|
2566
BlueLinx
BXC
$586M
| $8.17M | ﹤0.01% |
87,781
-11,901
| -12% | -$1.26M |
2017 Q2
28 quarters
|
|
2567
PUT
Cigna
CI
$71B
| $8.17M | ﹤0.01% |
24,700
-5,000
| -17% | -$1.72M |
2021 Q3
11 quarters
|
|
2568
CALL
Bath & Body Works
BBWI
$3.27B
| $8.16M | ﹤0.01% |
208,900
+90,100
| +76% | +$4.14M |
2020 Q2
16 quarters
|
|
2569
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.06B
| $8.16M | ﹤0.01% |
202,737
-50,091
| -20% | -$2.01M |
2019 Q4
18 quarters
|
|
2570
Hanmi Financial
HAFC
$934M
| $8.14M | ﹤0.01% |
486,806
+124,481
| +34% | +$1.94M |
2013 Q2
44 quarters
|
|
|
AMED
2571
DELISTED
Amedisys
AMED
| $8.14M | ﹤0.01% |
88,636
-8,346
| -9% | -$774K |
2015 Q4
34 quarters
|
|
2572
Capital Group Dividend Value ETF
CGDV
$38.5B
| $8.12M | ﹤0.01% |
245,953
+29,356
| +14% | +$956K |
2023 Q1
5 quarters
|
|
2573
PUT
Universal Display
OLED
$3.63B
| $8.12M | ﹤0.01% |
38,600
-39,700
| -51% | -$6.98M |
2023 Q2
4 quarters
|
|
2574
CALL
Baxter International
BAX
$12.1B
| $8.11M | ﹤0.01% |
242,500
| – | – |
2022 Q4
6 quarters
|
|
2575
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.6B
| $8.1M | ﹤0.01% |
55,600
-169,400
| -75% | -$24.3M |
2021 Q3
11 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.